- Home
- SCNI vs NDRA Comparison
SCNI vs NDRA Comparison
Compare SCNI & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- NDRA
- Stock Information
- Founded
- SCNI 2003
- NDRA 2007
- Country
- SCNI Israel
- NDRA United States
- Employees
- SCNI N/A
- NDRA N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SCNI Health Care
- NDRA Health Care
- Exchange
- SCNI Nasdaq
- NDRA Nasdaq
- Market Cap
- SCNI 2.3M
- NDRA 2.3M
- IPO Year
- SCNI N/A
- NDRA 2017
- Fundamental
- Price
- SCNI $2.24
- NDRA $8.10
- Analyst Decision
- SCNI
- NDRA Strong Buy
- Analyst Count
- SCNI 0
- NDRA 1
- Target Price
- SCNI N/A
- NDRA $46.00
- AVG Volume (30 Days)
- SCNI 93.4K
- NDRA 4.9M
- Earning Date
- SCNI 08-14-2025
- NDRA 08-13-2025
- Dividend Yield
- SCNI N/A
- NDRA N/A
- EPS Growth
- SCNI N/A
- NDRA N/A
- EPS
- SCNI N/A
- NDRA N/A
- Revenue
- SCNI $658,000.00
- NDRA N/A
- Revenue This Year
- SCNI N/A
- NDRA N/A
- Revenue Next Year
- SCNI N/A
- NDRA N/A
- P/E Ratio
- SCNI N/A
- NDRA N/A
- Revenue Growth
- SCNI N/A
- NDRA N/A
- 52 Week Low
- SCNI $1.90
- NDRA $2.90
- 52 Week High
- SCNI $8.92
- NDRA $170.63
- Technical
- Relative Strength Index (RSI)
- SCNI 46.99
- NDRA 77.76
- Support Level
- SCNI $2.06
- NDRA $6.60
- Resistance Level
- SCNI $2.85
- NDRA $11.96
- Average True Range (ATR)
- SCNI 0.23
- NDRA 0.84
- MACD
- SCNI 0.01
- NDRA 0.59
- Stochastic Oscillator
- SCNI 30.38
- NDRA 56.06
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.